|
1
|
Xu X, Mao W, Chen Q, Zhuang Q, Wang L, Dai
J, Wang H and Huang Z: Endostar, a modified recombinant human
endostatin, suppresses angiogenesis through inhibition of
Wnt/β-catenin signaling pathway. PLoS One. 9:e1074632014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shin JM, Jeong YJ, Cho HJ, Park KK, Chung
IK, Lee IK, Kwak JY, Chang HW, Kim CH, Moon SK, et al: Melittin
suppresses HIF-1α/VEGF expression through inhibition of ERK and
mTOR/p70S6K pathway in human cervical carcinoma cells. PLoS One.
8:e693802013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jeong JH, Jeong YJ, Cho HJ, Shin JM, Kang
JH, Park KK, Park YY, Chung IK, Chang HW, Magae J, et al:
Ascochlorin inhibits growth factor-induced HIF-1α activation and
tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K
signaling pathway in human cervical carcinoma cells. J Cell
Biochem. 113:1302–1313. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De S, Chen J, Narizhneva NV, Heston W,
Brainard J, Sage EH and Byzova TV: Molecular pathway for cancer
metastasis to bone. J Biol Chem. 278:39044–39050. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeong YJ, Cho HJ, Magae J, Lee IK, Park KG
and Chang YC: Ascofuranone suppresses EGF-induced HIF-1α protein
synthesis by inhibition of the Akt/mTOR/p70S6K pathway in
MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol.
273:542–550. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hosseini H, Rajabibazl M, Ebrahimizadeh W
and Dehbidi GR: Inhibiting angiogenesis with human single-chain
variable fragment antibody targeting VEGF. Microvasc Res. 97:13–18.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferrara N and Davis-Smyth T: The biology
of vascular endothelial growth factor. Endocr Rev. 18:4–25. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boddy JL, Fox SB, Han C, Campo L, Turley
H, Kanga S, Malone PR and Harris AL: The androgen receptor is
significantly associated with vascular endothelial growth factor
and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a,
and the prolyl hydroxylases in human prostate cancer. Clin Cancer
Res. 11:7658–7663. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ren W, Mi D, Yang K, Cao N, Tian J, Li Z
and Ma B: The expression of hypoxia-inducible factor-1α and its
clinical significance in lung cancer: A systematic review and
meta-analysis. Swiss Med Wkly. 143:w138552013.PubMed/NCBI
|
|
12
|
Soggia A, Ramond C, Akiyama H, Scharfmann
R and Duvillie B: von Hippel-Lindau gene disruption in mouse
pancreatic progenitors and its consequences on endocrine
differentiation in vivo: Importance of HIF1-α and VEGF-A
upregulation. Diabetologia. 57:2348–2356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu Y, Lucia K, Lange M, Kuhlen D, Stalla
GK and Renner U: Hypoxia inducible factor-1 is involved in growth
factor, glucocorticoid and hypoxia mediated regulation of vascular
endothelial growth factor-A in human meningiomas. J Neurooncol.
119:263–273. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan B, Wang YX, Yao T and Zhu YC: p38
Mitogen-activated protein kinase mediates hypoxia-induced vascular
endothelial growth factor release in human endothelial cells. Sheng
Li Xue Bao. 57:13–20. 2005.PubMed/NCBI
|
|
15
|
Déry MA, Michaud MD and Richard DE:
Hypoxia-inducible factor 1: Regulation by hypoxic and non-hypoxic
activators. Int J Biochem Cell Biol. 37:535–540. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martin S, Favot L, Matz R, Lugnier C and
Andriantsitohaina R: Delphinidin inhibits endothelial cell
proliferation and cell cycle progression through a transient
activation of ERK-1/−2. Biochem Pharmacol. 65:669–675. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pal HC, Sharma S, Strickland LR, Agarwal
J, Athar M, Elmets CA and Afaq F: Delphinidin reduces cell
proliferation and induces apoptosis of non-small-cell lung cancer
cells by targeting EGFR/VEGFR2 signaling pathways. PLoS One.
8:e772702013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Favot L, Martin S, Keravis T,
Andriantsitohaina R and Lugnier C: Involvement of cyclin-dependent
pathway in the inhibitory effect of delphinidin on angiogenesis.
Cardiovasc Res. 59:479–487. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seo BN, Ryu JM, Yun SP, Jeon JH, Park SS,
Oh KB, Park JK and Han HJ: Delphinidin prevents hypoxia-induced
mouse embryonic stem cell apoptosis through reduction of
intracellular reactive oxygen species-mediated activation of JNK
and NF-κB, and Akt inhibition. Apoptosis. 18:811–824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lamy S, Blanchette M, Michaud-Levesque J,
Lafleur R, Durocher Y, Moghrabi A, Barrette S, Gingras D and
Béliveau R: Delphinidin, a dietary anthocyanidin, inhibits vascular
endothelial growth factor receptor-2 phosphorylation.
Carcinogenesis. 27:989–996. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Passaniti A, Taylor RM, Pili R, Guo Y,
Long PV, Haney JA, Pauly RR, Grant DS and Martin GR: A simple,
quantitative method for assessing angiogenesis and antiangiogenic
agents using reconstituted basement membrane, heparin, and
fibroblast growth factor. Lab Invest. 67:519–528. 1992.PubMed/NCBI
|
|
22
|
Ahn GO, Seita J, Hong BJ, Kim YE, Bok S,
Lee CJ, Kim KS, Lee JC, Leeper NJ, Cooke JP, et al: Transcriptional
activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells
promotes angiogenesis through VEGF and S100A8. Proc Natl Acad Sci
USA. 111:2698–2703. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ke Q and Costa M: Hypoxia-inducible
factor-1 (HIF-1). Mol Pharmacol. 70:1469–1480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu C, Shi Y, Du Y, Ning X, Liu N, Huang
D, Liang J, Xue Y and Fan D: Dual-specificity phosphatase DUSP1
protects overactivation of hypoxia-inducible factor 1 through
inactivating ERK MAPK. Exp Cell Res. 309:410–418. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Semenza G: Signal transduction to
hypoxia-inducible factor 1. Biochem Pharmacol. 64:993–998. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rojas M, Yao S and Lin YZ: Controlling
epidermal growth factor (EGF)-stimulated Ras activation in intact
cells by a cell-permeable peptide mimicking phosphorylated EGF
receptor. J Biol Chem. 271:27456–27461. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martin S, Giannone G, Andriantsitohaina R
and Martinez MC: Delphinidin, an active compound of red wine,
inhibits endothelial cell apoptosis via nitric oxide pathway and
regulation of calcium homeostasis. Br J Pharmacol. 139:1095–1102.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Afaq F, Zaman N, Khan N, Syed DN, Sarfaraz
S, Zaid MA and Mukhtar H: Inhibition of epidermal growth factor
receptor signaling pathway by delphinidin, an anthocyanidin in
pigmented fruits and vegetables. Int J Cancer. 123:1508–1515. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Semenza GL: HIF-1: mediator of
physiological and pathophysiological responses to hypoxia. J Appl
Physiol (1985). 88:1474–1480. 2000.PubMed/NCBI
|
|
30
|
Tong E, Xu Y, Li G, Zou K and Zou L: The
effects of β-elemene on the expression of mTOR, HIF-1A, survivin in
lung adenocarcinoma A549 cell. Afr J Tradit Complement Altern Med.
10:18–23. 2013.PubMed/NCBI
|
|
31
|
Lv L, Yuan J, Huang T, Zhang C, Zhu Z,
Wang L, Jiang G and Zeng F: Stabilization of Snail by HIF-1α and
TNF-α is required for hypoxia-induced invasion in prostate cancer
PC3 cells. Mol Biol Rep. 41:4573–4582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Badr GA, Zhang JZ, Tang J, Kern TS and
Ismail-Beigi F: Glut1 and glut3 expression, but not capillary
density, is increased by cobalt chloride in rat cerebrum and
retina. Brain Res Mol Brain Res. 64:24–33. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang GL and Semenza GL: Characterization
of hypoxia-inducible factor 1 and regulation of DNA binding
activity by hypoxia. J Biol Chem. 268:21513–21518. 1993.PubMed/NCBI
|
|
34
|
Epstein AC, Gleadle JM, McNeill LA,
Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI,
Dhanda A, et al: C. elegans EGL-9 and mammalian homologs define a
family of dioxygenases that regulate HIF by prolyl hydroxylation.
Cell. 107:43–54. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yuan Y, Hilliard G, Ferguson T and
Millhorn DE: Cobalt inhibits the interaction between
hypoxia-inducible factor-alpha and von Hippel-Lindau protein by
direct binding to hypoxia-inducible factor-alpha. J Biol Chem.
278:15911–15916. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Afaq F, Zaman N, Khan N, Syed DN, Sarfaraz
S, Zaid MA and Mukhtar H: Inhibition of epidermal growth factor
receptor signaling pathway by delphinidin, an anthocyanidin in
pigmented fruits and vegetables. Int J Cancer. 123:1508–1515. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Marhold M, Tomasich E, El-Gazzar A, Heller
G, Spittler A, Horvat R, Krainer M and Horak P: HIF1α regulates
mTOR signaling and viability of prostate cancer stem cells. Mol
Cancer Res. 13:556–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Park SJ, Ryu J, Kim IH, Choi YH and Nam
TJ: Activation of the mTOR signaling pathway in breast cancer MCF-7
cells by a peptide derived from Porphyra yezoensis. Oncol Rep.
33:19–24. 2014.PubMed/NCBI
|
|
39
|
Jefferies HB, Fumagalli S, Dennis PB,
Reinhard C, Pearson RB and Thomas G: Rapamycin suppresses 5′TOP
mRNA translation through inhibition of p70s6k. EMBO J.
16:3693–3704. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Minet E, Arnould T, Michel G, Roland I,
Mottet D, Raes M, Remacle J and Michiels C: ERK activation upon
hypoxia: Involvement in HIF-1 activation. FEBS Lett. 468:53–58.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ozbay T and Nahta R: Delphinidin inhibits
HER2 and Erk1/2 signaling and suppresses growth of
HER2-overexpressing and triple negative breast cancer cell lines.
Breast Cancer (Auckl). 5:143–154. 2011.PubMed/NCBI
|
|
42
|
Kondo Y, Arii S, Mori A, Furutani M, Chiba
T and Imamura M: Enhancement of angiogenesis, tumor growth, and
metastasis by transfection of vascular endothelial growth factor
into LoVo human colon cancer cell line. Clin Cancer Res. 6:622–630.
2000.PubMed/NCBI
|
